Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose N-Acetylcysteine in Cardiac Surgery
NCT00332631Phase 2Completed
- Sponsor
- Austin Health
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute kidney injury (AKI) comparing N-acetylcysteine with Placebo (2 arms). Primary endpoint: Absolute change in serum creatinine from baseline to peak level at 5 days. Started Aug 2004; status: completed.
02
Drugs
acetylcysteine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT00332631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332631.